6533b7d8fe1ef96bd126a391
RESEARCH PRODUCT
NUTRITION AND CANCER
Georgem. Martinsubject
Gerontologymedicine.medical_specialtyLung Neoplasmsbusiness.industryCancer therapyCancerGeneral MedicineDiseasePrecision medicinemedicine.diseasePatient populationAcquired resistanceNeoplasmsCarcinoma Squamous CellmedicineNutritional Physiological PhenomenaIntensive care medicinebusinessDiet Therapydescription
The last decades have seen the identification of a number of drugs targeting oncogene pathways, therefore contributing to moving the cancer therapy field toward precision medicine. However, existing and acquired resistance to targeted therapies represent major obstacles against their long-term effectiveness. In fact, the initial efficacy of targeted therapies is often limited to a portion of the patient population and is frequently followed by the acquisition of drug-resistant disease.
| year | journal | country | edition | language |
|---|---|---|---|---|
| 1969-11-08 | The Lancet |